{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:50:22Z","timestamp":1777593022456,"version":"3.51.4"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.mce.2016.12.011","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T12:46:26Z","timestamp":1482237986000},"page":"36-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The role of microRNAs in the pathophysiology of adrenal tumors"],"prefix":"10.1016","volume":"456","author":[{"given":"Nunki","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing Ting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stan B.","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2016.12.011_bib1","first-page":"405","article-title":"Adrenal incidentaloma. Best practice & research","volume":"26","author":"Arnaldi","year":"2012","journal-title":"Clin. Endocrinol. Metabolism"},{"key":"10.1016\/j.mce.2016.12.011_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mce.2016.12.011_bib3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/0218492312456979","article-title":"Tetralogy of Fallot with pheochromocytoma: an unusual therapeutic challenge","volume":"21","author":"Balakrishnan","year":"2013","journal-title":"Asian Cardiovasc. Thorac. Ann."},{"key":"10.1016\/j.mce.2016.12.011_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.mce.2016.12.011_bib5","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1530\/EJE-14-0113","article-title":"Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma","volume":"171","author":"Baudin","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2016.12.011_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/ERC-13-0415","article-title":"Long-term prognosis of patients with pediatric pheochromocytoma","volume":"21","author":"Bausch","year":"2014","journal-title":"Endocrine-related Cancer"},{"key":"10.1016\/j.mce.2016.12.011_bib7","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2265.2009.03725.x","article-title":"MicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumourigenesis","volume":"72","author":"Bimpaki","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.mce.2016.12.011_bib8","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm.1880","article-title":"The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities","volume":"14","author":"Bonci","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2016.12.011_bib9","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/sj.onc.1207277","article-title":"Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators","volume":"23","author":"Bourdeau","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2016.12.011_bib10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ccell.2016.03.013","article-title":"Genetic and epigenetic silencing of MicroRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression","volume":"29","author":"Bueno","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mce.2016.12.011_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1261\/rna.351707","article-title":"The imprinted H19 noncoding RNA is a primary microRNA precursor","volume":"13","author":"Cai","year":"2007","journal-title":"RNA (New York, N.Y.)"},{"key":"10.1016\/j.mce.2016.12.011_bib12","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2016.12.011_bib13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/ERC-13-0098","article-title":"Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma","volume":"20","author":"Caramuta","year":"2013","journal-title":"Endocrine-related Cancer"},{"key":"10.1016\/j.mce.2016.12.011_bib14","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1038\/ncomms7044","article-title":"Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas","volume":"6","author":"Castro-Vega","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mce.2016.12.011_bib15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1530\/ERC-13-0051","article-title":"Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients","volume":"20","author":"Chabre","year":"2013","journal-title":"Endocrine-related Cancer"},{"key":"10.1016\/j.mce.2016.12.011_bib16","first-page":"195","article-title":"microRNAs as potential biomarkers in adrenocortical cancer: progress and challenges","volume":"6","author":"Cherradi","year":"2015","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mce.2016.12.011_bib17","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.ajpath.2011.07.002","article-title":"Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas","volume":"179","author":"Cheunsuchon","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2016.12.011_bib18","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2016.12.011_bib19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Comino-Mendez","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mce.2016.12.011_bib20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/ERC-12-0183","article-title":"Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways","volume":"20","author":"de Cubas","year":"2013","journal-title":"Endocrine-related Cancer"},{"key":"10.1016\/j.mce.2016.12.011_bib21","article-title":"IGF2-derived miR-483 mediated oncofunction by suppressing DLC-1 and associated with colorectal cancer","author":"Cui","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2016.12.011_bib22","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1158\/1535-7163.MCT-14-0209","article-title":"Systemic delivery of a miR34a mimic as a potential therapeutic for liver cancer","volume":"13","author":"Daige","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.mce.2016.12.011_bib23","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/oxfordjournals.molbev.a004169","article-title":"Evolution of transcription factor binding sites in Mammalian gene regulatory regions: conservation and turnover","volume":"19","author":"Dermitzakis","year":"2002","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.mce.2016.12.011_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2012.08.014","article-title":"Efficacy of the novel dual PI3-kinase\/mTOR inhibitor NVP-BEZ235 in a preclinical model of adrenocortical carcinoma","volume":"364","author":"Doghman","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2016.12.011_bib25","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1158\/0008-5472.CAN-09-3970","article-title":"Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors","volume":"70","author":"Doghman","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2016.12.011_bib26","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.humpath.2014.04.005","article-title":"MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations","volume":"45","author":"Duregon","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.mce.2016.12.011_bib27","doi-asserted-by":"crossref","first-page":"15093","DOI":"10.18632\/oncotarget.7618","article-title":"Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer","volume":"7","author":"Dwivedi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2016.12.011_bib28","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1373\/clinchem.2014.224832","article-title":"Laboratory evaluation of pheochromocytoma and paraganglioma","volume":"60","author":"Eisenhofer","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mce.2016.12.011_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2105-4-57","article-title":"Conservation of regulatory elements between two species of Drosophila","volume":"4","author":"Emberly","year":"2003","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.mce.2016.12.011_bib30","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.mce.2016.12.011_bib31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12022-011-9189-0","article-title":"Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma","volume":"23","author":"Favier","year":"2012","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.mce.2016.12.011_bib32","first-page":"981","article-title":"P-glycoprotein expression and multidrug resistance in adrenocortical carcinoma","volume":"112","author":"Flynn","year":"1992","journal-title":"Surgery"},{"key":"10.1016\/j.mce.2016.12.011_bib33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.mce.2016.12.011_bib34","article-title":"A\u00a0chromosome 16p13.11 microduplication causes hyperactivity through dysregulation of miR-484\/protocadherin-19 signaling","author":"Fujitani","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.mce.2016.12.011_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nrg2504","article-title":"Small silencing RNAs: an expanding universe","volume":"10","author":"Ghildiyal","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.mce.2016.12.011_bib36","doi-asserted-by":"crossref","first-page":"36675","DOI":"10.18632\/oncotarget.5383","article-title":"MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma","volume":"6","author":"Glover","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2016.12.011_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/ERC-14-0457","article-title":"Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence","volume":"22","author":"Glover","year":"2015","journal-title":"Endocrine-related Cancer"},{"key":"10.1016\/j.mce.2016.12.011_bib38","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.mce.2016.12.011_bib39","doi-asserted-by":"crossref","first-page":"s63","DOI":"10.1007\/s00280-006-0318-2","article-title":"RNAi, microRNAs, and human disease","volume":"58","author":"Hammond","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.mce.2016.12.011_bib40","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1101\/gad.1262504","article-title":"The Drosha-DGCR8 complex in primary microRNA processing","volume":"18","author":"Han","year":"2004","journal-title":"Genes & Dev."},{"key":"10.1016\/j.mce.2016.12.011_bib41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/JOE-11-0427","article-title":"Liposomal doxorubicin-based treatment in a preclinical model of adrenocortical carcinoma","volume":"213","author":"Hantel","year":"2012","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.mce.2016.12.011_bib42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/ERC-13-0439","article-title":"Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model","volume":"21","author":"Hantel","year":"2014","journal-title":"Endocrine-related Cancer"},{"key":"10.1016\/j.mce.2016.12.011_bib43","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/cen.12814","article-title":"Downregulation of miR-375 in aldosterone-producing adenomas promotes tumour cell growth via MTDH","volume":"83","author":"He","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.mce.2016.12.011_bib44","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/nmeth1130","article-title":"Using expression profiling data to identify human microRNA targets","volume":"4","author":"Huang","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.mce.2016.12.011_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrg2936","article-title":"Gene silencing by microRNAs: contributions of translational repression and mRNA decay","volume":"12","author":"Huntzinger","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.mce.2016.12.011_bib46","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1158\/0008-5472.CAN-09-0155","article-title":"MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling","volume":"69","author":"Iliopoulos","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2016.12.011_bib47","doi-asserted-by":"crossref","first-page":"e101423","DOI":"10.1371\/journal.pone.0101423","article-title":"ZNF367 inhibits cancer progression and is targeted by miR-195","volume":"9","author":"Jain","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.mce.2016.12.011_bib48","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11912-013-0320-x","article-title":"Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma","volume":"15","author":"Jimenez","year":"2013","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.mce.2016.12.011_bib49","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1158\/0008-5472.CAN-07-1083","article-title":"The let-7 microRNA represses cell proliferation pathways in human cells","volume":"67","author":"Johnson","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2016.12.011_bib50","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrc3166","article-title":"Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy","volume":"11","author":"Kasinski","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mce.2016.12.011_bib51","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.ejca.2013.02.034","article-title":"Adrenocortical carcinoma: a population-based study on incidence and survival in The Netherlands since 1993","volume":"49","author":"Kerkhofs","year":"2013","journal-title":"Eur. J. Cancer (Oxford, Engl. 1990)"},{"key":"10.1016\/j.mce.2016.12.011_bib52","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1158\/0008-5472.CAN-07-5194","article-title":"Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer","volume":"68","author":"Kozaki","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2016.12.011_bib53","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/cdd.2008.69","article-title":"miR-203 represses 'stemness' by repressing DeltaNp63","volume":"15","author":"Lena","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mce.2016.12.011_bib54","doi-asserted-by":"crossref","first-page":"E674","DOI":"10.1210\/jc.2013-2900","article-title":"Lower expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone-producing adenoma causing human primary aldosteronism","volume":"99","author":"Lenzini","year":"2014","journal-title":"J.\u00a0Clin. Endocrinol. Metabolism"},{"key":"10.1016\/j.mce.2016.12.011_bib55","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1158\/1078-0432.CCR-12-3325","article-title":"Targeting miR-21 inhibits in\u00a0vitro and in\u00a0vivo multiple myeloma cell growth","volume":"19","author":"Leone","year":"2013","journal-title":"Clin. Cancer Res. official J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.mce.2016.12.011_bib56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mce.2013.10.028","article-title":"Genetics and epigenetics of adrenocortical tumors","volume":"386","author":"Lerario","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2016.12.011_bib57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.mce.2016.12.011_bib58","doi-asserted-by":"crossref","first-page":"15535","DOI":"10.1073\/pnas.0808266105","article-title":"Distinct microRNA expression profiles in acute myeloid leukemia with common translocations","volume":"105","author":"Li","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.mce.2016.12.011_bib59","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.22757","article-title":"MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma","volume":"49","author":"Li","year":"2009","journal-title":"Hepatol. Baltim. Md.)"},{"key":"10.1016\/j.mce.2016.12.011_bib60","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1158\/1078-0432.CCR-10-1800","article-title":"Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer","volume":"17","author":"Li","year":"2011","journal-title":"Clin. cancer Res. official J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.mce.2016.12.011_bib61","first-page":"124","article-title":"Characterization of NCI-H295R cells as an in\u00a0vitro model of hyperaldosteronism","volume":"45","author":"Lichtenauer","year":"2013","journal-title":"Hormone Metabolic Res.\u00a0= Hormon- und Stoffwechselforschung\u00a0= Hormones Metabolisme"},{"key":"10.1016\/j.mce.2016.12.011_bib62","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1126\/science.1102513","article-title":"Argonaute2 is the catalytic engine of mammalian RNAi","volume":"305","author":"Liu","year":"2004","journal-title":"Sci. (New York, N.Y.)"},{"key":"10.1016\/j.mce.2016.12.011_bib63","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.18632\/oncotarget.3255","article-title":"MiR-195 suppresses non-small cell lung cancer by targeting CHEK1","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2016.12.011_bib64","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature10888","article-title":"The microcosmos of cancer","volume":"482","author":"Lujambio","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.mce.2016.12.011_bib65","first-page":"2088","article-title":"Tumor-suppressive microRNA-195-5p regulates cell growth and inhibits cell cycle by targeting cyclin dependent kinase 8 in colon cancer","volume":"8","author":"Luo","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.mce.2016.12.011_bib102","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ccr.2007.03.012","article-title":"Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics","volume":"11","author":"MacDiarmid","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mce.2016.12.011_bib66","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1677\/ERC-10-0142","article-title":"MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets","volume":"17","author":"Meyer-Rochow","year":"2010","journal-title":"Endocrine-related Cancer"},{"key":"10.1016\/j.mce.2016.12.011_bib67","unstructured":"NCT01829971. (https:\/\/clinicaltrials.gov\/ct2\/show\/)."},{"key":"10.1016\/j.mce.2016.12.011_bib68","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molcel.2008.05.001","article-title":"MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation","volume":"30","author":"Orom","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mce.2016.12.011_bib69","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/RCT.0b013e31829cbecf","article-title":"Serendipity in the diagnosis of pheochromocytoma","volume":"37","author":"Oshmyansky","year":"2013","journal-title":"J.\u00a0Comput. Assisted Tomogr."},{"key":"10.1016\/j.mce.2016.12.011_bib70","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1530\/ERC-11-0082","article-title":"The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma","volume":"18","author":"Ozata","year":"2011","journal-title":"Endocrine-related Cancer"},{"key":"10.1016\/j.mce.2016.12.011_bib71","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1158\/0008-5472.CAN-08-1305","article-title":"MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells","volume":"68","author":"Papagiannakopoulos","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2016.12.011_bib72","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrg3162","article-title":"MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship","volume":"13","author":"Pasquinelli","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.mce.2016.12.011_bib73","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.surg.2013.06.022","article-title":"MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors","volume":"154","author":"Patel","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.mce.2016.12.011_bib74","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/cncr.25724","article-title":"MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy","volume":"117","author":"Patterson","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.mce.2016.12.011_bib75","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1530\/ERC-11-0308","article-title":"The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma","volume":"19","author":"Patterson","year":"2012","journal-title":"Endocrine-related Cancer"},{"key":"10.1016\/j.mce.2016.12.011_bib76","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1073\/pnas.0707594105","article-title":"MicroRNA-373 induces expression of genes with complementary promoter sequences","volume":"105","author":"Place","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2016.12.011_bib77","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.10421","article-title":"Metformin as a new anti-cancer drug in adrenocortical carcinoma","author":"Poli","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2016.12.011_bib78","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nature18632","article-title":"Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma","volume":"535","author":"Powers","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.mce.2016.12.011_bib79","article-title":"Chronic treatment with the mood stabilizing drug lithium up-regulates nuclear factor E2-related factor 2 in rat pheochromocytoma PC12 cells in\u00a0vitro","author":"Rizak","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.mce.2016.12.011_bib80","doi-asserted-by":"crossref","first-page":"851","DOI":"10.15252\/emmm.201100899","article-title":"Development of microRNA therapeutics is coming of age","volume":"6","author":"van Rooij","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mce.2016.12.011_bib81","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.phrs.2007.07.001","article-title":"Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in\u00a0vitro","volume":"56","author":"Rossi","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mce.2016.12.011_bib82","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jcp.2010.085621","article-title":"Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours","volume":"64","author":"Schmitz","year":"2011","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.mce.2016.12.011_bib83","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0092-8674(03)00759-1","article-title":"Asymmetry in the assembly of the RNAi enzyme complex","volume":"115","author":"Schwarz","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.mce.2016.12.011_bib84","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mce.2011.09.041","article-title":"Dysregulation of microRNAs in adrenocortical tumors","volume":"351","author":"Singh","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2016.12.011_bib85","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/CBI20100204","article-title":"MicroRNA-488 suppresses cell migration through modulation of the focal adhesion activity during chondrogenic differentiation of chick limb mesenchymal cells","volume":"35","author":"Song","year":"2011","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.mce.2016.12.011_bib86","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.1158\/1078-0432.CCR-09-1587","article-title":"miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer","volume":"15","author":"Soon","year":"2009","journal-title":"Clin. Cancer Res. official J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.mce.2016.12.011_bib87","doi-asserted-by":"crossref","first-page":"22724","DOI":"10.18632\/oncotarget.4261","article-title":"Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma","volume":"6","author":"de Sousa","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2016.12.011_bib88","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/jcmm.12522","article-title":"DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1","volume":"19","author":"Sun","year":"2015","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.mce.2016.12.011_bib89","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/labinvest.2013.148","article-title":"Analysis of circulating microRNAs in adrenocortical tumors","volume":"94","author":"Szabo","year":"2014","journal-title":"Lab. Investigation; a J. Tech. Methods Pathol."},{"key":"10.1016\/j.mce.2016.12.011_bib90","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11060-012-1027-9","article-title":"MicroRNA-183 upregulates HIF-1alpha by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells","volume":"111","author":"Tanaka","year":"2013","journal-title":"J.\u00a0Neuro-oncology"},{"key":"10.1016\/j.mce.2016.12.011_bib91","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant mitotane treatment for adrenocortical carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.mce.2016.12.011_bib92","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","article-title":"Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors","volume":"65","author":"Tissier","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2016.12.011_bib93","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1677\/ERC-09-0096","article-title":"Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis","volume":"16","author":"Tombol","year":"2009","journal-title":"Endocrine-related Cancer"},{"key":"10.1016\/j.mce.2016.12.011_bib94","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/modpathol.2010.164","article-title":"MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas","volume":"23","author":"Tombol","year":"2010","journal-title":"Mod. Pathology Official J. U. S. Can. Acad. Pathol., Inc"},{"key":"10.1016\/j.mce.2016.12.011_bib95","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ccr3.6","article-title":"Pheochromocytoma crisis","volume":"2","author":"Tschuor","year":"2014","journal-title":"Clin. case Rep."},{"key":"10.1016\/j.mce.2016.12.011_bib96","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1073\/pnas.0801615105","article-title":"Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2016.12.011_bib97","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3892\/or.2016.4797","article-title":"Downregulation of miR-195 promotes prostate cancer progression by targeting HMGA1","volume":"36","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.mce.2016.12.011_bib98","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive Pan-Genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mce.2016.12.011_bib99","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12185-015-1829-6","article-title":"Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia","volume":"102","author":"Zhi","year":"2015","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.mce.2016.12.011_bib100","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/JME-12-0008","article-title":"MEG3 noncoding RNA: a tumor suppressor","volume":"48","author":"Zhou","year":"2012","journal-title":"J.\u00a0Mol. Endocrinol."},{"key":"10.1016\/j.mce.2016.12.011_bib101","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/IGC.0000000000000686","article-title":"MiR-195 suppresses cervical cancer migration and invasion through targeting Smad3","volume":"26","author":"Zhou","year":"2016","journal-title":"Int. J. Gynecol. Cancer Official J. Int. Gynecol. Cancer Soc."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720716305184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720716305184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T19:25:30Z","timestamp":1568661930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720716305184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":102,"alternative-id":["S0303720716305184"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2016.12.011","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of microRNAs in the pathophysiology of adrenal tumors","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2016.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}